{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:44:42Z","timestamp":1787798682635,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-024-03293-7","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:50:04Z","timestamp":1732776604000},"page":"93-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recovery of right ventricular function in patients with transthyretin cardiac amyloidosis after one-year tafamidis administration"],"prefix":"10.1007","volume":"41","author":[{"given":"Tomoo","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ijichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"3293_CR1","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","volume":"142","author":"MM Kittleson","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV et al (2020) Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation 142:e7\u2013e22","journal-title":"Circulation"},{"key":"3293_CR2","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, Devit M et al (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci USA 109:9629\u20139634","journal-title":"Proc Natl Acad Sci USA"},{"key":"3293_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40120-015-0031-3","volume":"4","author":"M Waddington Cruz","year":"2015","unstructured":"Waddington Cruz M, Benson MD (2015) A review of tafamidis for the treatment of transthyretin-related amyloidosis. Neurol Ther 4:61\u201379","journal-title":"Neurol Ther"},{"key":"3293_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379:1007\u20131016","journal-title":"N Engl J Med"},{"key":"3293_CR5","doi-asserted-by":"publisher","first-page":"e008193","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193","volume":"15","author":"P Elliott","year":"2022","unstructured":"Elliott P, Drachman BM, Gottlieb SS et al (2022) Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy. Circ Heart Fail 15:e008193","journal-title":"Circ Heart Fail"},{"key":"3293_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jchf.2020.09.011","volume":"9","author":"C Rapezzi","year":"2021","unstructured":"Rapezzi C, Elliott P, Damy T et al (2021) Efficacy of tafamidis in patients with hereditary and wild-type transthyretin amyloid cardiomyopathy: further analyses from ATTR-ACT. JACC Heart Fail 9:115\u2013123","journal-title":"JACC Heart Fail"},{"key":"3293_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1536\/ihj.23-075","volume":"64","author":"Y Nakaya","year":"2023","unstructured":"Nakaya Y, Ogimoto A, Kitaoka H (2023) Changes in exercise tolerance over time in patients with transthyretin amyloidosis cardiomyopathy treated with tafamidis. Int Heart J 64:647\u2013653","journal-title":"Int Heart J"},{"key":"3293_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ehjci\/jead030","volume":"24","author":"R Rettl","year":"2023","unstructured":"Rettl R, Wollenweber T, Duca F et al (2023) Monitoring tafamidis treatment with quantitative SPECT\/CT in transthyretin amyloid cardiomyopathy. Eur Heart J Cardiovasc Imaging 24:1019\u20131030","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3293_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","volume":"60","author":"SJ Buss","year":"2012","unstructured":"Buss SJ, Emami M, Mereles D et al (2012) Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol 60:1067\u20131076","journal-title":"J Am Coll Cardiol"},{"key":"3293_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jjcc.2022.02.010","volume":"80","author":"H Usuku","year":"2022","unstructured":"Usuku H, Takashio S, Yamamoto E et al (2022) Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy. J Cardiol 80:56\u201363","journal-title":"J Cardiol"},{"key":"3293_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.123.066524","volume":"14","author":"A Porcari","year":"2024","unstructured":"Porcari A, Fontana M, Canepa M et al (2024) Clinical and prognostic implications of right ventricular uptake on bone scintigraphy in transthyretin amyloid cardiomyopathy. Circulation 14:1157\u20131168","journal-title":"Circulation"},{"key":"3293_CR12","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/ehf2.14380","volume":"10","author":"S Takashio","year":"2023","unstructured":"Takashio S, Morioka M, Ishii M, et al et al (2023) Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy. ESC Heart Fail 10:2319\u20132329","journal-title":"ESC Heart Fail"},{"key":"3293_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1253\/circj.CJ-21-0965","volume":"86","author":"Y Ochi","year":"2022","unstructured":"Ochi Y, Kubo T, Baba Y et al (2022) Early experience of tafamidis treatment in Japanese patients with wild-type transthyretin cardiac amyloidosis from the Kochi Amyloidosis Cohort. Circ J 86:1121\u20131128","journal-title":"Circ J"},{"key":"3293_CR14","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","volume":"84","author":"H Kitaoka","year":"2020","unstructured":"Kitaoka H, Izumi C, Izumiya Y et al (2020) JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J 84:1610\u20131671","journal-title":"Circ J"},{"key":"3293_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1253\/circj.CJ-19-0811","volume":"84","author":"J Endo","year":"2019","unstructured":"Endo J, Sano M, Izumiya Y et al (2019) A statement on the appropriate administration of tafamidis in patients with transthyretin cardiac amyloidosis. Circ J 84:15\u201317","journal-title":"Circ J"},{"key":"3293_CR16","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1093\/eurheartj\/ehac259","volume":"43","author":"S Law","year":"2022","unstructured":"Law S, Bezard M, Petrie A et al (2022) Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. Eur Heart J 43:2622\u20132632","journal-title":"Eur Heart J"},{"key":"3293_CR17","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/ehf2.13847","volume":"9","author":"N Nakashima","year":"2022","unstructured":"Nakashima N, Takashio S, Morioka M et al (2022) A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan. ESC Heart Fail 9:1731\u20131739","journal-title":"ESC Heart Fail"},{"key":"3293_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32:1\u201364","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277\u2013314","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1\u201339","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2011.01.015","volume":"24","author":"V Mor-Avi","year":"2011","unstructured":"Mor-Avi V, Lang RM, Badano LP et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 24:277\u2013313","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, Kolias TJ, Muraru D et al (2018) Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19:591\u2013600","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3293_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.echo.2015.01.021","volume":"28","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Takeuchi M, Mizukoshi K et al (2015) Intervendor variability of two-dimensional strain using vendor-specific and vendor-independent software. J Am Soc Echocardiogr 28:630\u2013641","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.echo.2018.01.008","volume":"31","author":"ZJ Il\u2019Giovine","year":"2018","unstructured":"Il\u2019Giovine ZJ, Mulder H, Chiswell K et al (2018) Right ventricular longitudinal strain reproducibility using vendor-dependent and vendor-independent software. J Am Soc Echocardiogr 31:721\u2013732","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/ehjci\/jez246","volume":"21","author":"M Gavazzoni","year":"2020","unstructured":"Gavazzoni M, Badano LP, Vizzardi E et al (2020) Prognostic value of right ventricular free wall longitudinal strain in a large cohort of outpatients with left-side heart disease. Eur Heart J Cardiovasc Imaging 21:1013\u20131021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3293_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/ehjci\/jew011","volume":"18","author":"DA Morris","year":"2017","unstructured":"Morris DA, Krisper M, Nakatani S et al (2017) Normal range and usefulness of right ventricular systolic strain to detect subtle right ventricular systolic abnormalities in patients with heart failure: a multicentre study. Eur Heart J Cardiovasc Imaging 18:212\u2013223","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3293_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.echo.2010.05.009","volume":"23","author":"A Meris","year":"2010","unstructured":"Meris A, Faletra F, Conca C et al (2010) Timing and magnitude of regional right ventricular function: a speckle tracking-derived strain study of normal subjects and patients with right ventricular dysfunction. J Am Soc Echocardiogr 23:823\u2013831","journal-title":"J Am Soc Echocardiogr"},{"key":"3293_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1253\/circj.CJ-11-0778","volume":"76","author":"S Guendouz","year":"2012","unstructured":"Guendouz S, Rappeneau S, Nahum J et al (2012) Prognostic significance and normal values of 2D strain to assess right ventricular systolic function in chronic heart failure. Circ J 76:127\u2013136","journal-title":"Circ J"},{"key":"3293_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1540-8175.2011.01594.x","volume":"29","author":"DP Leong","year":"2012","unstructured":"Leong DP, Grover S, Molaee P et al (2012) Nonvolumetric echocardiographic indices of right ventricular systolic function: validation with cardiovascular magnetic resonance and relationship with functional capacity. Echocardiography 29:455\u2013463","journal-title":"Echocardiography"},{"key":"3293_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/echo.12783","volume":"32","author":"KJ Lu","year":"2015","unstructured":"Lu KJ, Chen JX, Profitis K et al (2015) Right ventricular global longitudinal strain is an independent predictor of right ventricular function: a multimodality study of cardiac magnetic resonance imaging, real time threedimensional echocardiography and speckle tracking echocardiography. Echocardiography 32:966\u2013974","journal-title":"Echocardiography"},{"key":"3293_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4250\/jcu.2014.22.3.113","volume":"22","author":"JH Park","year":"2014","unstructured":"Park JH, Negishi K, Kwon DH et al (2014) Validation of global longitudinal strain and strain rate as reliable markers of right ventricular dysfunction:comparison with cardiac magnetic resonance and outcome. J Cardiovasc Ultrasound 22:113\u2013120","journal-title":"J Cardiovasc Ultrasound"},{"key":"3293_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ehjci\/jeab226","volume":"23","author":"R Rettl","year":"2022","unstructured":"Rettl R, Mann C, Duca F et al (2022) Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy. Eur Heart J Cardiovasc Imaging 23:767\u2013780","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3293_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/13506129.2022.2131385","volume":"30","author":"R Rettl","year":"2023","unstructured":"Rettl R, Duca F, Binder C et al (2023) Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy. Amyloid 30:127\u2013137","journal-title":"Amyloid"},{"key":"3293_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2023.4147","volume":"9","author":"SJ Shah","year":"2024","unstructured":"Shah SJ, Fine N, Garcia-Pavia P et al (2024) Effect of tafamidis on cardiac function in patients with transthyretin amyloid cardiomyopathy: a post hoc analysis of the ATTR-ACT randomized clinical trial. JAMA Cardiol 9:25\u201334","journal-title":"JAMA Cardiol"},{"key":"3293_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/ehjci\/jead344","volume":"25","author":"RH Nishizawa","year":"2024","unstructured":"Nishizawa RH, Kawano H, Yoshimuta T et al (2024) Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 25:678\u2013686","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03293-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-024-03293-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03293-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T04:06:36Z","timestamp":1737086796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-024-03293-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["3293"],"URL":"https:\/\/doi.org\/10.1007\/s10554-024-03293-7","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board for Clinical Research of Tokai University School of Medicine approved this protocol. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}